Returns
Every filed return on the register. Filter, then open any return on lobbying.ie to read it in full.
Showing returns naming Erin McGreehan .
Filed returns
328
match these filters
| Period | Registrant | Policy area | Subject, as filed | Officials named | Link |
|---|---|---|---|---|---|
| May–Aug 2026 | The Irish Clinical Oncology Group t/a Cancer Trials Ireland | Health | Pre-Budget submission document concerning cancer clinical trials (Matters involving public funds) | 30 | On lobbying.ie |
| May–Aug 2026 | The Irish Hospice Foundation | Health | Follow up letter of thanks for the opportunity to contribute to the discussion on the challenges and opportunities facing palliative care (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2026 | Health Promotion Alliance Ireland | Health | Commercial Determinants of Health (Public policy or programme) | 9 | On lobbying.ie |
| May–Aug 2026 | Health Promotion Alliance Ireland | Health | Commercial Determinants of Health (Public policy or programme) | 338 | On lobbying.ie |
| May–Aug 2026 | Dexcom | Health | Diabetes Policy in Ireland (Public policy or programme) | 24 | On lobbying.ie |
| May–Aug 2026 | AstraZeneca Pharmaceuticals (Ireland) DAC | Health | Meeting to discuss a Proposal for an Early Access Programme for Innovative Medicines (Public policy or programme) | 2 | On lobbying.ie |
| May–Aug 2026 | Irish Sudden Infant Death Association | Health | A Submission to the Joint Committee on Health on the Need for a National, Trauma-Informed Post-Loss Psychological Care Pathway (Public policy or programme) | 8 | On lobbying.ie |
| May–Aug 2026 | Hanover Media Strategy Limited | Health | Discussion of proposed Early Access Programme of innovative oncology medicines (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2026 | Takeda Products Ireland | Health | Rare disease policy in Ireland (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2026 | Novartis Ireland Limited | Health | Valuing Innovation & Advanced Cancer Therapy - policy and access (Public policy or programme) | 27 | On lobbying.ie |
| May–Aug 2026 | Irish Cancer Society | Health | Childhood, adolescent and young adult cancers (Public policy or programme) | 1 | On lobbying.ie |
| May–Aug 2026 | Irish Cancer Society | Health | National Cancer Strategy (Public policy or programme) | 14 | On lobbying.ie |
| May–Aug 2026 | Irish Cancer Society | Health | Tobacco Products Directive and Tobacco Advertising Directive (Legislation) | 1 | On lobbying.ie |
| May–Aug 2026 | The Alzheimer Society of Ireland | Health | Prebudget Submission Briefing (Matters involving public funds) | 78 | On lobbying.ie |
| May–Aug 2026 | GSK | Health | Vaccines policy (Public policy or programme) | 21 | On lobbying.ie |
| May–Aug 2026 | The Health Policy Partnership | Health | Radioligand therapy in Ireland/ heart failure (Public policy or programme) | 43 | On lobbying.ie |
| May–Aug 2026 | Mental Health Reform | Health | Budget 2027 (Matters involving public funds) | 30 | On lobbying.ie |
| May–Aug 2026 | Irish Heart Foundation | Health | Online marketing of unhealthy food. (Public policy or programme) | 17 | On lobbying.ie |
| May–Aug 2026 | Cheshire Ireland | Health | Submission of Pre Budget Submission (Matters involving public funds) | 232 | On lobbying.ie |
| May–Aug 2026 | BioMarin International Limited | Health | Rare disease policy in Ireland and the EU (Public policy or programme) | 19 | On lobbying.ie |
| May–Aug 2026 | Diabetes Ireland | Health | To seek sustained investment in supporting people living with diabetes and promote a more strategic approach to addressing long term improvements making huge government cost savings, increase Oireachtas members… (Public policy or programme) | 30 | On lobbying.ie |
| May–Aug 2026 | InnoSphere Consulting | Health | Ovarian cancer (Public policy or programme) | 3 | On lobbying.ie |
| May–Aug 2026 | Acquired Brain Injury Ireland | Health | Pre-Budget submission priorities (Public policy or programme) | 48 | On lobbying.ie |
| May–Aug 2026 | InnoSphere Consulting | Health | Global Human Exposome Project (Public policy or programme) | 5 | On lobbying.ie |
| May–Aug 2026 | InnoSphere Consulting | Health | Global Human Exposome Project (Public policy or programme) | 6 | On lobbying.ie |
| May–Aug 2026 | Neurological Alliance of Ireland | Health | Seeking investment in order to deliver on programme for government commitments to neurology and neurorehabilitation services. Support for EU neurological health strategy during Irelands EU Presidency (Public policy or programme) | 65 | On lobbying.ie |
| May–Aug 2026 | Pfizer | Health | Expansion of the National Immunisation Programme to include RSV vaccination for older adults (Public policy or programme) | 16 | On lobbying.ie |
| May–Aug 2026 | Irish Family Planning Association | Health | National and international policy on sexual and reproductive health and rights (SRHR) (Public policy or programme) | 28 | On lobbying.ie |
| May–Aug 2026 | FND Ireland | Health | FND Ireland made written submissions to public representatives and policy stakeholders, including a Pre-Budget 2027 submission, advocating for investment in specialist multidisciplinary FND services,… (Public policy or programme) | 54 | On lobbying.ie |
| Jan–Apr 2026 | FND Ireland | Health | FND Healthcare services in Ireland (Public policy or programme) | 28 | On lobbying.ie |
| Jan–Apr 2026 | The Irish Clinical Oncology Group t/a Cancer Trials Ireland | Health | Launch of INSPIRE radiotherapy trial, a cross-border trial for prostate cancer patients (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | The Irish Clinical Oncology Group t/a Cancer Trials Ireland | Health | Jan 27th 2026 - a meeting in Leinster House with Erin McGreehan, TD about CTI's Value of Cancer Trials Report and about workforce issues relating to cancer clinical trials (Public policy or programme) | 1 | On lobbying.ie |
| Jan–Apr 2026 | Reduced Risk Products Association Company Limited | Health | The Reduced Risk Products Association briefed Deputies ahead of the Second Stage debate on the Public Health (Tobacco Products and Nicotine Inhaling Products) (Amendment) Bill 2026. The RRPA supports measures to reduce… (Legislation) | 173 | On lobbying.ie |
| Jan–Apr 2026 | Reduced Risk Products Association Company Limited | Health | The Reduced Risk Products Association issued correspondence to all TDs and Senators highlighting concerns about enforcement capacity within Ireland’s vaping sector. The communication stressed that the effectiveness of… (Legislation) | 332 | On lobbying.ie |
| Jan–Apr 2026 | Stratagem (NI) Ltd | Health | Provision of audiology services and eye care services (Public policy or programme) | 6 | On lobbying.ie |
| Jan–Apr 2026 | Early Onset Parkinsons Disease CLG | Health | Leinster House AV Room policy briefing on 21 April 2026 and associated follow-up correspondence with Oireachtas members regarding challenges facing people living with Early Onset Parkinson’s Disease in Ireland,… (Public policy or programme) | 40 | On lobbying.ie |
| Jan–Apr 2026 | Irish Heart Foundation | Health | Oireachtas Heart and Stroke Group - Women's Heart Health (Public policy or programme) | 13 | On lobbying.ie |
| Jan–Apr 2026 | Irish Heart Foundation | Health | Oireachtas Heart and Stroke Group- Unregulated Junk Food Marketing (Public policy or programme) | 55 | On lobbying.ie |
| Jan–Apr 2026 | Vulcan Consulting Limited | Health | Organising an event to launch a Cancer Dashboard for Ireland (Public policy or programme) | 45 | On lobbying.ie |
| Jan–Apr 2026 | Dexcom | Health | Diabetes Policy in Ireland (Public policy or programme) | 43 | On lobbying.ie |
| Jan–Apr 2026 | Novartis Ireland Limited | Health | Supporting a Health Policy Partnership Initiative for them to run a roundtable and draft a white paper with policy stakeholders. (Public policy or programme) | 26 | On lobbying.ie |
| Jan–Apr 2026 | Vulcan Consulting Limited | Health | Diabetes Policy in Ireland (Public policy or programme) | 35 | On lobbying.ie |
| Jan–Apr 2026 | Novartis Ireland Limited | Health | Implementation of the decision to include SMA in newborn screening (Matters involving public funds) | 10 | On lobbying.ie |
| Jan–Apr 2026 | Irish Cancer Society | Health | Daffodil Day (Public policy or programme) | 77 | On lobbying.ie |
| Jan–Apr 2026 | Irish Cancer Society | Health | Timely access to healthcare and cancer care services (Public policy or programme) | 12 | On lobbying.ie |
| Jan–Apr 2026 | Irish Cancer Society | Health | Cancer care infrastructure (Matters involving public funds) | 12 | On lobbying.ie |
| Jan–Apr 2026 | Irish Cancer Society | Health | Costs of cancer (Public policy or programme) | 14 | On lobbying.ie |
| Jan–Apr 2026 | Irish Cancer Society | Health | Sunbed regulation (Public policy or programme) | 13 | On lobbying.ie |
| Jan–Apr 2026 | Diabetes Ireland | Health | To seek sustained investment in supporting people living with diabetes and promote a more strategic approach to addressing long term improvements making huge government cost savings, increase Oireachtas members… (Public policy or programme) | 37 | On lobbying.ie |
| Jan–Apr 2026 | Neurological Alliance of Ireland | Health | Access to Neurology Services across Ireland (Public policy or programme) | 29 | On lobbying.ie |
Policy areas in these returns
| Public policy area | Filed returns | Share | Relative to the largest |
|---|---|---|---|
| Health | 328 | 100.0% |